Abstract
Patient-Reported Quality of Life (QoL) Following CTL019 Infusion in Adult Patients (pts) with Relapsed/Refractory (r/r) Diffuse Large B-Cell Lymphoma (DLBCL)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have